AMLX Stock Price Prediction 2025, 2030 2040

If you’re seeking insights into AMLX stock Price prediction or interested in its potential, this price forecast could provide valuable information. Our AMLX Stock Price Prediction relies on in-depth technical analysis and historical performance data of AMLX (TAmylyx Pharmaceuticals Inc) Stock. Here, we aim to evaluate the long-term potential of AMLX Stock.

AMLX Stock Price Prediction 2025, 2030 2040

About Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc. is a prominent global pharmaceutical firm dedicated to crafting remedies for neurode generative disorders. Here’s a comprehensive breakdown:

Mission and Focus:

  • Amylyx is committed to devising and commercializing treatments for relentless neurodegenerative ailments like ALS and Alzheimer’s Disease, aiming to enhance patient lives and foster cherished moments.

Products:

  • Their flagship investigational drug, AMX0035 (RELYVRIO® in the US, ALBRIOZA™ in Canada), is currently undergoing ALS clinical trials, comprising sodium phenylbutyrate and taurursodiol.
  • Additionally, Amylyx is exploring potential treatments for diverse neurodegenerative diseases in its early-stage pipeline.

Recent Developments:

  • The Phase 3 PHOENIX Trial (August 2023) for ALS treatment with AMX0035 didn’t meet primary or secondary endpoints; further data analysis is ongoing.

Financial Performance:

  • Amylyx is publicly listed on the Nasdaq as AMLX, though comprehensive financial data may be limited due to its relative youth.

Criticisms and Controversies:

  • The high cost of AMX0035 and inconclusive PHOENIX trial outcomes have sparked debate.
  • Patients should consult physicians to grasp treatment benefits and risks thoroughly.

AMLX Stock Price Prediction 2024 to 2050

YearAverageLowHigh
2024$32.34$1.4054$35.10
2025$8.138$7.888$37.39
2026$24.57$0.0985$29.26
2027$10.24$9.7276$32.84
2028$13.42$0.9203$18.27
2029$7.8378$7.2378$28.30
2030$5.4235$0.0241$12.37
2035$2.1776$0.6253$21.88
2040$19.08$0.4589$15.35
2045$27.30$19.24$47.40
2050$27.23$20.81$57.61

AMLX Stock Price Prediction 2024

For the Amylyx Pharmaceuticals Inc Stock (AMLX) price projection in 2024, analysts anticipate an average price target of $18.25, with a high forecast of $35.10 and a low forecast of $1.4054. This forecast indicates a significant increase of +840.13% from the previous price of $3.44.

AMLX Stock Price Prediction 2025

In 2025, Amylyx Pharmaceuticals Inc Stock (AMLX) is projected to achieve an average price of $22.64, with a high prediction of $37.39 and a low estimate of $7.888. This suggests a significant increase of +136.57% from the previous recorded price of $3.44.

AMLX Stock Price Prediction 2026

The price forecast for Amylyx Pharmaceuticals Inc Stock (AMLX) in 2026 averages $14.68. Projections vary from a high of $29.26 to a low of $0.0985, indicating a substantial +614.32% increase from the preceding price of $3.44.

AMLX Stock Price Prediction 2027

In 2027, the anticipated average price target for Amylyx Pharmaceuticals Inc Stock (AMLX) is $21.28, with a high projection of $32.84 and a low forecast of $9.7276. This suggests a notable +197.60% increase from the recent price of $3.44.

AMLX Stock Price Prediction 2028

Amylyx Pharmaceuticals Inc Stock (AMLX) is anticipated to attain an average price of $9.5942 in 2028, with a high projection of $18.27 and a low estimate of $0.9203. This implies a substantial +290.01% increase from the previous price of $3.44.

AMLX Stock Price Prediction 2029

The projected price for Amylyx Pharmaceuticals Inc Stock (AMLX) in 2029 averages at $17.77, with a high prediction of $28.30 and a low estimate of $7.2378. This reflects a significant +127.84% increase from the previous price of $3.44.

AMLX Stock Price Prediction 2030

Amylyx Pharmaceuticals Inc Stock (AMLX) is anticipated to achieve an average price of $6.1952 in 2030, with a high forecast of $12.37 and a low forecast of $0.0241. This indicates a notable +57.66% surge from the previous price of $3.44.

Disclaimer:The information in this article is solely the author’s opinion and does not constitute investment advice; it is provided solely for educational purposes. By using this, you acknowledge that the information does not constitute investment or financial advice. Before making any investment decisions, do your own research and consult with financial advisors.

Disclaimer:

The information in this article is solely the author’s opinion and does not constitute investment advice; it is provided solely for educational purposes. By using this, you acknowledge that the information does not constitute investment or financial advice. Before making any investment decisions, do your own research and consult with financial advisors.

Read more

Leave a Comment